San Francisco, April 20, 2016 -- The Vitamin D Testing market is estimated to reach at more than CAGR of 32.35% from 2013 to 2018. The major reason for the development of this market is the increase in the geriatric population and chronic illness globally. The vitamin D testing market is observing approval for the increase in the products. Nevertheless, requirement for strict rules can present confront to the raise of the market.
Browse Full Research Report With TOC on http://www.radiantinsights.com/research/global-vitamin-d-testing-market-2014-2018
The market is estimated to observe a stable growth in the future. The viewpoint for the development of the market depends on features including major incidence of vitamin D shortage in the people resulting into moderate but slow growth of the market. The avoidance of different chronic and acute sickness is the major driver for the vitamin D testing market growth.
Chronic sicknesses like osteoporosis and rickets can occur due to deficiency of vitamin D. Vitamin D deficiency can also lead to asthma in infants, cardiovascular diseases, cognitive disorder, autoimmune diseases, and cancer. Frequent checking of the level of vitamin D in the body can reduce the occurrence of these diseases. This would in turn lower the overall expenditure related to healthcare.
See More Reports of This Category by Radiant Insights: www.radiantinsights.com/catalog/healthcare
The 25-Hydroxy vitamin D tests & 1, 25-Dihydroxy vitamin test sectors are estimated to be the largest market sector over the forecast period. At present this market sector holds a share of over three forth of the total market and is estimated to remain dominant over the forecast period. The capability of 25-Hydroxy vitamin D test has significant role in identifying bone weakness, bone softness & malfunction, or fracture in adult which is estimated to result in high share of the market over the forecast phase.
The market is extremely cutthroat and has companies focusing on research and development of tests. These companies compete on the ground of quality, product line width, price, technology, & distribution ability to get maximum importance in the market.
Get Sample Report Copy @ www.radiantinsights.com/research/global-vitamin-d-testing-market-2014-2018#tabs-4
The major companies in this market include Roche Diagnostics, Siemens Healthcare Diagnostics, Abbott Diagnostics, Quest Diagnostics, and Biomeriux Diasorin. Vitamin D testing kit at homes is gaining fame being highly price efficient.
Explore Other Reports By Radiant Insights,Inc at
- Butyl Acetate Markets –
http://www.radiantinsights.com/research/butyl-acetate-markets-in-china
- Cyanuramide Markets –
http://www.radiantinsights.com/research/cyanuramide-markets-in-china
About Radiant Insights
Radiant Insights is a market research and consulting company offering syndicated research studies, customized reports, and consulting services. Our market research studies are designed to facilitate strategic decision making, on the basis of extensive and in-depth quantitative information, supported by extensive analysis and industry insights. Using a patented and robust research methodology, we publish exhaustive research reports covering a host of industries such as Technology, Chemicals, Materials, and Energy.Radiant Insights has a strong base of analysts, consultants and domain experts, with global experience helping us deliver excellence in all research projects we undertake.
Contact Details:
Michelle Thoras
Corporate Sales Specialist, USA
Radiant Insights, Inc
Phone: 1-415-349-0054
Toll Free: 1-888-202-9519
Email: [email protected]
Web: http://www.radiantinsights.com/


FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
Italy Fines Apple €98.6 Million Over App Store Dominance
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
Boeing Seeks FAA Emissions Waiver to Continue 777F Freighter Sales Amid Strong Cargo Demand
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
Seatrium Reaches $475 Million Settlement With Maersk Over Offshore Wind Vessel Project
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties 



